BioInnovation Institute invests in three international start-ups

The BioInnovation Institute (BII), an international commercial non-profit foundation incubating and accelerating life science research set up by the Novo Nordisk Foundation, has announced its investment into three international start-up companies from the UK, Germany, and Finland.

The Danish organization operates an incubator to accelerate world-class life science innovation that drives the development of new solutions by early life science start-ups by offering state-of-the-art labs, vibrant office facilities, business development, start-up business incubation, access to high-level mentoring and international networks, plus unique funding opportunities of up to $1.3 million per start-up and $2.4 million per project.

The three new ventures are strategically aligned with the BII’s focus, developing innovative scientific initiatives across the therapeutics and health tech space.